2025
SJR Q1
JCR Q1 · 8,3
31 matched articles
SCIE
Journal detail
Diabetes/Metabolism Research and Reviews
- Publisher
- John Wiley and Sons Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
1520755215207560
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 2,03
- Quartile Q1
- H-Index 146
- Cites/doc 8,03
- Docs (3y) 352
- Cites (3y) 2.746
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 8,3
- 5Y JIF 7,2
- JCI 1,36
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Endocrinology Q1
- Endocrinology, Diabetes and Metabolism Q1
- Internal Medicine Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Endocrinology & Metabolism
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 2,03 | 8,3 | 7,2 | 1,36 | Q1 | 146 |
| 2024 | Q1 | Q1 | 1,792 | 6 | 6,6 | 1,4 | Q1 | 141 |
| 2023 | Q1 | Q1 | 1,991 | 4,6 | 6,4 | 1,54 | Q1 | 141 |
| 2022 | Q1 | Q1 | 1,863 | 8 | 6,3 | 1,43 | Q1 | 141 |
| 2021 | Q1 | Q1 | 1,781 | 8,1 | 6,6 | 1,37 | Q1 | 141 |
| 2020 | Q1 | Q2 | 1,307 | 4,9 | 5,3 | 0,87 | Q2 | 141 |
| 2019 | Q1 | Q2 | 1,567 | 3,3 | 4 | 1,02 | Q1 | 141 |
| 2018 | — | Q1 | — | 4,8 | 4,1 | 1,06 | Q1 | — |
| 2017 | Q1 | Q2 | 1,807 | 3,9 | 3,8 | 1,03 | Q1 | 141 |
| 2016 | Q1 | Q2 | 1,297 | 3,3 | 3,5 | — | — | 141 |
| 2015 | Q1 | Q2 | 1,68 | 3,1 | 3,5 | — | — | 141 |
| 2014 | Q1 | Q2 | 1,57 | 3,6 | 3,4 | — | — | 141 |
| 2013 | Q1 | Q2 | 1,482 | 3,6 | 3,6 | — | — | 141 |
| 2012 | Q1 | Q2 | 1,195 | 3 | 3,2 | — | — | 141 |
| 2011 | Q1 | Q2 | 1,327 | 3,4 | 3,1 | — | — | 141 |
| 2010 | Q1 | Q2 | 1,553 | 3,1 | 3,3 | — | — | 141 |
| 2009 | — | Q2 | — | 2,8 | 3,1 | — | — | — |
| 2008 | — | Q2 | — | 3,1 | 3,3 | — | — | — |
| 2007 | — | Q2 | — | 3,1 | 2,9 | — | — | — |
| 2006 | — | Q2 | — | 2,6 | — | — | — | — |
| 2005 | — | Q2 | — | 2,5 | — | — | — | — |
| 2004 | — | Q2 | — | 3,1 | — | — | — | — |
| 2003 | — | Q2 | — | 3 | — | — | — | — |
| 2002 | — | Q2 | — | 2,5 | — | — | — | — |
| 2001 | — | Q3 | — | 1,9 | — | — | — | — |
| 2000 | — | Q2 | — | 2,2 | — | — | — | — |
| 1999 | — | Q2 | — | 2,4 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 15/198 |
| 2024 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 28/193 |
| 2023 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 36/186 |
| 2022 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 16/145 |
| 2021 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 21/146 |
| 2020 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 44/146 |
| 2019 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q1 | 64/143 |
| 2018 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 28/145 |
| 2017 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q1 | 39/142 |
| 2016 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 61/138 |
| 2015 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 61/133 |
| 2014 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 47/128 |
| 2013 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 45/124 |
| 2012 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 54/122 |
| 2011 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 45/122 |
| 2010 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 51/116 |
| 2009 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 49/105 |
| 2008 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 40/93 |
| 2007 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 36/92 |
| 2006 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 42/93 |
| 2005 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 41/89 |
| 2004 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 28/87 |
| 2003 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 29/88 |
| 2002 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 37/88 |
| 2001 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 49/90 |
| 2000 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 40/89 |
| 1999 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 29/85 |